Cencora, Inc.

COR Healthcare Medical Distribution

Cencora, Inc.’s revenue for fiscal 2025 (year ended September 2025) was $321.3 billion, up 9.31% from fiscal 2024. In the quarter to June 2026, revenue grew 5.07%, EPS grew 11.3%, free cash flow grew 3,385.3% and total debt rose 42.3%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for three consecutive years, revenue growth for ten; insiders bought in the last twelve months.

340.66 0.75 −0.22%
Market cap
$65.2B
P/E
25.2×
Fwd P/E
14.5×
Dividend yield
0.70%
F-score
6/9
Altman Z
4.83
Beneish M
−2.54
Dividend safety
74/100
Older periods Sep '25 Dec '25 Mar '26 Jun '26
P/E ratio

+8 more quarters

38.97 40.30 23.94 20.93
P/S ratio
0.19 0.20 0.19 0.16
P/FCF ratio
18.89 17.97 38.15 13.31
P/Operating CF
19.33 (28.46) 45.65 20.59
P/B ratio
34.67 31.30 17.05 16.87
EV/Sales
0.20 0.22 0.22 0.19
EV/EBITDA
17.28 19.22 18.58 15.46
EV/FCF
19.92 19.66 44.52 15.48
Current Ratio
0.90 0.92 0.95 0.93
Net Debt/EBITDA
11.70 6.02 7.26 6.37
Debt/Equity
4.38 3.78 3.45 3.62
Earnings Yield
2.57% 2.48% 4.18% 4.78%
Free Cash Flow Yield
5.29% 5.56% 2.62% 7.51%
Free Cash Flow per Share
14.88 (12.26) 6.03 12.58
Book value per Share
9.01 10.79 18.43 16.77
Free Cash Flow
2,883.61 (2,381.49) 1,173.74 2,430.06
EV/EBIT
24.30 26.75 25.57 20.90
Other line items

Show all line items

Columns are period end dates